Compounds > fludarabine

fludarabine and Psoriasis

fludarabine has been researched along with Psoriasis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buckley, C; Hoffbrand, AV; Smith, OP1
Hayag, MV; Nouri, K; Taylor, JR; Tie, C1
Akça, S; Karadoğan, I; Undar, L1
Nagler, A; Or, R; Slavin, S; Varadi, G1
Bryon, RJ; Chakrabarti, S; Griffiths, MJ; Handa, SK; Milligan, DW1

Other Studies

5 other study(ies) available for fludarabine and Psoriasis

ArticleYear
Fludarabine and psoriasis.
    The New England journal of medicine, 1994, May-26, Volume: 330, Issue:21

    Topics: Aged; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Psoriasis; Vidarabine

1994
Topical treatment of psoriasis with fludarabine.
    Cutis, 1997, Volume: 59, Issue:5

    Topics: Administration, Topical; Antineoplastic Agents; Dermatologic Agents; Humans; Male; Psoriasis; Vidarabine

1997
Resolution of psoriatic skin lesions with fludarabine.
    The American journal of medicine, 1999, Volume: 107, Issue:3

    Topics: Antineoplastic Agents; CD4-Positive T-Lymphocytes; Humans; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Vidarabine

1999
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
    Experimental hematology, 2000, Volume: 28, Issue:7

    Topics: Adult; Antineoplastic Agents; Arthritis, Psoriatic; Autoimmunity; Busulfan; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytes; Male; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; Vidarabine

2000
Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?
    Transplantation, 2001, Jul-27, Volume: 72, Issue:2

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lenograstim; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Nuclear Family; Psoriasis; Recombinant Proteins; T-Lymphocyte Subsets; Transplantation Chimera; Vidarabine

2001